| Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine LR Baden, HM El Sahly, B Essink, K Kotloff, S Frey, R Novak, D Diemert, ... New England journal of medicine 384 (5), 403-416, 2021 | 10026 | 2021 |
| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1477 | 2020 |
| Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, ... New England Journal of Medicine 385 (19), 1774-1785, 2021 | 520 | 2021 |
| Nirmatrelvir plus ritonavir for early COVID-19 in a large US health system: a population-based cohort study S Dryden-Peterson, A Kim, AY Kim, EC Caniglia, IT Lennes, R Patel, ... Annals of internal medicine 176 (1), 77-84, 2023 | 110 | 2023 |
| Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system S Dryden-Peterson, A Kim, AY Kim, EC Caniglia, I Lennes, R Patel, ... medRxiv, 2022 | 31 | 2022 |
| Relationship Between Myocardial Injury During Index Hospitalization for SARS‐CoV‐2 Infection and Longer‐Term Outcomes B Weber, H Siddiqi, G Zhou, J Vieira, A Kim, H Rutherford, X Mitre, ... Journal of the American Heart Association 11 (1), e022010, 2022 | 31 | 2022 |
| Determining the incidence of asymptomatic SARS-CoV-2 among early recipients of COVID-19 vaccines (DISCOVER-COVID-19): a prospective cohort study of healthcare workers before … CM North, A Barczak, RH Goldstein, BC Healy, DM Finkelstein, DD Ding, ... Clinical Infectious Diseases 74 (7), 1275-1278, 2022 | 24 | 2022 |
| Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis M Moll, RL Zon, KW Sylvester, J Rimsans, EC Chen, AJ Ghosh, E Abston, ... Thrombosis Research 203, 57-60, 2021 | 11 | 2021 |
| Humoral immunogenicity of the mRNA-1273 vaccine in the phase 3 Coronavirus Efficacy (COVE) trial HM El Sahly, LR Baden, B Essink, D Montefiori, A McDermont, R Rupp, ... The Journal of Infectious Diseases 226 (10), 1731-1742, 2022 | 10 | 2022 |
| Bebtelovimab for high-risk outpatients with early COVID-19 in a large US health system S Dryden-Peterson, A Kim, MR Joyce, JA Johnson, AY Kim, LR Baden, ... Open Forum Infectious Diseases 9 (11), ofac565, 2022 | 10 | 2022 |
| Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study S Naz-McLean, A Kim, A Zimmer, H Laibinis, J Lapan, P Tyman, J Hung, ... Plos one 17 (6), e0269127, 2022 | 8 | 2022 |
| Prior SARS‐CoV‐2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography B Weber, S Parks, DM Huck, A Kim, C Bay, JM Brown, S Divakaran, ... Journal of the American Heart Association 11 (20), e025844, 2022 | 4 | 2022 |
| Durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 vaccine trial DY Lin, LR Baden, HM El Sahly, B Essink, KM Neuzil, L Corey, J Miller, ... JAMA Network Open 5 (6), e2215984-e2215984, 2022 | 4 | 2022 |
| Serum sodium, patient symptoms, and clinical outcomes in hospitalized patients with covid-19 TE Yen, A Kim, ME Benson, S Ratnaparkhi, AE Woolley, FR Mc Causland Journal of Primary Care & Community Health 13, 21501319211067349, 2022 | 3 | 2022 |
| At-home testing and risk factors for acquisition of SARS-CoV-2 infection in a major US Metropolitan area AE Woolley, S Dryden-Peterson, A Kim, S Naz-McLean, C Kelly, ... Open Forum Infectious Diseases 9 (11), ofac505, 2022 | 2 | 2022 |
| Impact of interleukin-6 receptor blockade with tocilizumab on cardiac injury in patients with COVID-19: a retrospective cohort study BN Weber, G Zhou, A Kim, JC Pearson, J Stone, M DiCarli, S Nikiforow, ... Open Forum Infectious Diseases 8 (2), ofab012, 2021 | 2 | 2021 |
| Relationships between myocardial injury, index hospitalization characteristics, and longer-term outcomes in sars-cov-2 infection B Weber, H Siddiqi, J Vieira, G Zhou, A Kim, H Rutherford, X Mitre, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 3025-3025, 2021 | 1 | 2021 |
| Statin use and outcomes in hospitalized patients with sars-cov-2 infection H Siddiqi, J Vieira, B Weber, A Kim, H Rutherford, A Varshney, A Bhatt, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 3091-3091, 2021 | 1 | 2021 |
| Long-term outcomes in heart and lung transplants from HCV-viremic donors to uninfected recipients: the DONATE HCV trial AE Woolley, HJ Goldberg, SK Singh, MR Mehra, MM Givertz, A Coppolino, ... The Journal of Heart and Lung Transplantation 40 (4), S73, 2021 | 1 | 2021 |
| 427. Variation in SARS-CoV-2 molecular diagnostic test performance in symptomatic versus asymptomatic populations S Kanjilal, M Baker, AE Woolley, C Rhee, AK Petrides, J Kim, R Patel, ... Open Forum Infectious Diseases 7 (Suppl 1), S280, 2020 | 1 | 2020 |
